Chardon Pharma started a clinical study in endometriosis patiënts to characterize and quantify pain complaints. The study is a collaboration with the Rijnstate hospital in Arnhem and the Radboud University in Nijmegen.
Third patent filed
Chardon Pharma filed its third patent, entitled: ‘Use of selected N-phenyl benzamide variants for the stimulation of osteoblast activity and for the treatment of Osteoporosis and related disorders.’